NYSE:RMD
ResMed Inc Stock News
$213.26
+1.68 (+0.794%)
At Close: May 24, 2024
ResMed (RMD) Q1 Earnings Surpass Estimates, Margins Down
09:02am, Friday, 27'th Oct 2023
ResMed's (RMD) solid revenue growth in the first quarter of fiscal 2024 reflects the strength of AirSense 10 and AirSense 11 sleep devices and robust growth in the mask product portfolio.
ResMed Inc. (RMD) Q1 2024 Earnings Call Transcript
09:52pm, Thursday, 26'th Oct 2023
ResMed Inc. (NYSE:RMD ) Q1 2024 Results Conference Call October 26, 2023 4:30 PM ET Company Participants Amy Wakeham - Chief Communications and Investor Relations Officer Mick Farrell - Chief Executiv
ResMed (RMD) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
07:35pm, Thursday, 26'th Oct 2023
Although the revenue and EPS for ResMed (RMD) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Stree
ResMed (RMD) Beats Q1 Earnings and Revenue Estimates
06:48pm, Thursday, 26'th Oct 2023
ResMed (RMD) came out with quarterly earnings of $1.64 per share, beating the Zacks Consensus Estimate of $1.63 per share. This compares to earnings of $1.51 per share a year ago.
MedTech Earnings in the Age of Ozempic May Not Be That Bad
02:01pm, Tuesday, 17'th Oct 2023
September-quarter earnings among medical-device makers may prove better than expected in the age of weight-loss drugs.
Jim Cramer is weighing out the risks of weight loss drugs
07:36pm, Wednesday, 11'th Oct 2023
'Mad Money' host Jim Cramer takes a deep dive into the impact of obesity drugs on various sectors.
ResMed (RMD) Gains From Strong Device Sales Amid Macro Woes
12:46pm, Monday, 09'th Oct 2023
ResMed's (RMD) respiratory care business continues to drive growth and the adoption of bilevel and other non-invasive ventilator solutions worldwide.
ResMed to Report First Quarter Fiscal 2024 Earnings on October 26, 2023
04:05pm, Thursday, 05'th Oct 2023
SAN DIEGO, Oct. 05, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2024 on Thursday, O
Here's Why Investors Should Retain ResMed (RMD) Stock for Now
10:32am, Tuesday, 03'rd Oct 2023
Investors continue to be optimistic about ResMed (RMD) due to the core business' performance and sustained growth in the SaaS business.
Will ResMed Stock Rebound To Its Pre-Inflation Shock Highs Of $300?
09:00am, Monday, 02'nd Oct 2023
This compares with the Sharpe of 1.3 for the Trefis Reinforced Value portfolio.
Here are 11 stocks Jim Cramer is watching, including Buffett's Berkshire and restaurant stocks
10:17am, Friday, 29'th Sep 2023
Here are some of the tickers on my radar for Friday, Sept. 29, taken directly from my reporter's notebook.
ResMed (RMD) Stock Jumps 3.8%: Will It Continue to Soar?
07:31am, Thursday, 28'th Sep 2023
ResMed (RMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Wall Street analysts expect the S&P 500 to rise 19% over the next 12 months. Here are their 10 favorite stocks.
08:38am, Tuesday, 26'th Sep 2023
Outside of a handful of highflying technology stocks, U.S. stocks have been practically flat in 2023, but on Wall Street, some analysts remain as bullish as ever.
ResMed - Trading Opportunity Now
03:27pm, Tuesday, 12'th Sep 2023
ResMed is the global leader in the sleep apnea market. Sales growth accelerated during COVID and again recently as a result of a product recall from its major competitor. Despite a strong last quarter
ResMed Announces Participation in Upcoming Conferences
04:05pm, Tuesday, 05'th Sep 2023
SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced its participation in two upcoming conferences.
